Latest Biotechnology, Pharmaceutical and Healthcare News from BioPortfolio

16:32 EDT 20th August 2018 | BioPortfolio

Here are the most relevant search results for "BioPortfolio" found in our extensive news archives from over 250 global news sources.

More Information about BioPortfolio on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about BioPortfolio for you to read. Along with our medical data and news we also list BioPortfolio Clinical Trials, which are updated daily. BioPortfolio also has a large database of BioPortfolio Companies for you to search.

Showing News Articles 1–25 of 4,700+ from BioPortfolio

Thursday 16th August 2018

Leaf Expression Systems appoints Simon Saxby as new Chief Executive Officer

15th August 2018: Norwich, UK: Leaf Expression Systems, a contract biopharmaceutical development business specialising in plant-based expression of proteins, metabolites and complex natural products, announced today that life sciences veteran Simon J.Y Saxby has joined the company as Chief Executive Officer. The appointment comes as Leaf Expression System’s multi-million pound purpose-b...

Wednesday 15th August 2018

A1M Pharma to prioritize the indication acute kidney injuries in further development of ROSgard™ on the basis of positive preclinical data

August 15th 2018: A1M Pharma is today announcing the company’s decision to prioritize the indication acute kidney injuries in conjunction with heart surgery in the long-term clinical development plan for the drug candidate ROSgard™. This decision is based on the recently communicated positive results from preclinical studies in relevant research models. After completion of a Phase...

First Wave Launches First Sales into Korea & Taiwan - Establishes Foothold in Asian Markets

  August 15, 2018 – Batavia, New York – First Wave Products Group, LLC, a subsidiary of First Wave Technologies, Inc. (“First Wave” and “company”), announced an expansion of the company’s international presence into the APAC region—including South Korea and Taiwan.  First Wave is now serving clients at a global level and furthering i...

Tuesday 14th August 2018

AIM Pharma appoints CMO as clinic nears for ROSgard™ kidney protection drug

August 14th 2018: A1M Pharma announces that the company has appointed Tobias Larsson Agervald as its new Chief Medical Officer (CMO). Tobias Larsson Agervald is an associated professor and specialist in internal medicine and nephrology with extensive experience in global research and development of pharmaceuticals in both early and later clinical stages. He will assume the position on Decembe...

Friday 10th August 2018

A1M Pharma’s candidate drug ROSgard™ shows protective effect against acute kidney injury in US study

A1M Pharma AB (publ), 556755-3226 Press release 2018-08-10. A1M Pharma announces that the company's candidate drug ROSgard™ shows a strong protective effect against acute kidney injury (AKI) in a preclinical study conducted in the USA in collaboration with Indiana University. The positive results correlate well with recently reported results from a similar study conducted in Euro...

Thursday 9th August 2018

Immunovia`s blood-based IMMray™ biomarker array provides highly accurate diagnosis of non-small cell lung cancer in a new collaborative study with a major global pharma company

August 9th 2019 LUND, SWEDEN ― Immunovia AB announced today that in a new collaborative study with a major global pharma company, Immunovia ́s innovative blood-based testing platform, IMMray™ could differentiate healthy controls from non-small cell lung cancer (NSCLC) samples with a 95 % accuracy. Accounting for nearly 14% of all new cancers, NSCLC is one of the top three cancer type...

Tuesday 31st July 2018

US Patent granted for Follicum's FOL005 protein-based hair restoration product

31st July 2018: Follicum AB ("Follicum") announces that the U.S. Patent Office (USPTO) has issued a Notice of Allowance for their patent application 15/184,290 which is the company’s second, follow-up application which when granted confers expanded protection for Follicum's product candidate FOL-005. Follicum has already an approved US patent in this patent family, speci...

Monday 23rd July 2018

Following Investment, MedPharm Ltd Strengthens its Board with Three New Members

  July 23rd 2018: MedPharm Ltd., a leading provider of contract topical and transdermal product design and formulation development services, is pleased to introduce three new members to its Board of Directors. MedPharm has announced the appointment of three new members to its Board of Directors following an investment by Ampersand Capital Partners (“Ampersand”) in the Com...

A1M Pharma reports positive results from preclinical study in acute kidney injuries

July 23rd 2018: A1M Pharma today reports positive results from a preclinical study in the field of acute kidney injury (AKI). The primary endpoints show that the active substance in the company’s candidate drug, ROSgard™, significantly reduces the damaging effects on kidneys following exposure to severe oxidative stress. The study is a stage in A1M Pharma’s previously anno...

Tuesday 17th July 2018

First Wave Brings on Ken Rutt as Strategic Consultant

  Expertise Supports Development of the CLARITY-IA™ Respirator July 17, 2018 – Batavia, New York – Medical Conservation Device, a subsidiary of First Wave Technologies, Inc. (“First Wave” and “company”), announces that the company has engaged the consulting services of Ken Rutt, a senior level mechanical engineer and project engineer with o...

Thursday 28th June 2018

Consensus Orthopedics Featured in Q2 2018 Emerging Medical Technologies Spotlight

June 28, 2018 El Dorado Hills, CA – Consensus Orthopedics, Inc. (“Consensus”), an innovative orthopedics company, has been selected to present in the Life Science Intelligence Q2 2018 Emerging Medical Technologies Spotlight. The event is scheduled for Friday, June 29, 2018 at 1 p.m. EDT (10:00 a.m. PDT).  Access to the Consensus presentation and executive summary...

MedPharm Licenses Its MedSpray® ‘Patch-in-a-Can’ Technology to Virpax Pharmaceuticals for Non-Opioid Pain Management Products

GUILDFORD, UK – June 28, 2018 -- MedPharm, the world leader in topical and transdermal development,  licensed its unique MedSpray® technology to Virpax Pharmaceuticals (“Virpax”), a company based in Pennsylvania, US that is specialising in developing pharmaceutical products for pain management by using new drug delivery systems. MedSpray is covered by worldwide pate...

Wednesday 27th June 2018

First Wave Expands into Kaiser Permanente Network - Relationship Provides Entry into the Acute Care Market

June 27, 2018 – Batavia, New York – First Wave Products Group, LLC, a subsidiary of First Wave Technologies, Inc. (“First Wave” and “company”), announces that the company has expanded its customer base by signing a new client within the Kaiser Permanente hospital network.   The new client, The Kaiser Permanente Antioch Medical Center, located on t...

Tuesday 26th June 2018

Follicum successfully develops direct-to-scalp formulation to replace intradermal injections for first-in-class peptide-based FOL-005 hair loss drug candidate

June 26th 2018: Follicum AB ("Follicum" or "Company") today announced that the company has developed a new cosmetically appealing direct-to-scalp formulation of its leading peptide drug candidate FOL-005 for topical treatment of hair loss which will be used in future clinical trials. In Follicum's ongoing Phase IIa study, patients with hair loss are being treated wit...

Biotech Crop Adoption Leads to Greater Sustainability and Socioeconomic Opportunities for Global Farmers and Citizens - PG Economics & ISAAA

   Two new studies show continued environmental and social benefits of biotech crop use and adoption (June 26, 2018) – Today, the International Service for the Acquisition of Agri-biotech Applications (ISAAA) and PG Economics, Ltd. released new studies highlighting the continued social, environmental and economic benefits of the global adoption of

Monday 25th June 2018

HeartSciences Showcases MyoVista® Wavelet ECG at the 2018 International Congress on Electrocardiology (ICE)

SOUTHLAKE, Texas, June 25, 2018 -- (BioPortfolio) — HeartSciences, an innovative medical device company, is proud to announce its participation as an exhibitor at the upcoming 2018 International Congress on Electrocardiology (ICE), which will be held in Makuhari Messe, Chiba City, Japan, June 28-30, 2018. ICE2018 will be the joint meeting of the 45th Congress of the International Societ...

Wednesday 2nd May 2018

HeartSciences Announces Professor Peter Macfarlane Joins Clinical Advisory Board

Southlake, Texas – May 2, 2018 – HeartSciences, a U.S.-based medical device company that is leading innovation in the field of electrocardiology through the application of continuous wavelet transform (CWT) signal processing and artificial intelligence, announced today that Peter W. Macfarlane has joined its board of clinical advisors.  Professor Peter W. Macfarlane, DSc eF...

Sleek, new blue G:BOX multi-application imaging range from Syngene - Produces real images for accurate quantification of DNA, visible proteins & Western blots

May 1st 2018 Cambridge, UK: Syngene, a world-leading manufacturer of image analysis solutions, is delighted to introduce its new look G:BOX range of upgradeable multi-application  imaging systems. Designed with a sleek new darkroom, each of these systems includes top quality imaging features, making it easy for scientists to accurately quantify DNA and protein on all types of gels and bl...

Thursday 12th April 2018


Oslo – April 11 - Lytix Biopharma, an immune-oncology company focused on using oncolytic peptides to induce immunogenic cancer cell death , will present data at the 2018 American Association for Cancer Research (AACR) Annual Meeting taking place from 14th – 18th April 2018 at McCormick Place North/South, Chicago, Illinois, US. Dr Mikael J. Pittet,  Associate Professor at Ha...

Tuesday 10th April 2018

HeartSciences Announces Publication of Clinical Study Results in the Journal of the American College of Cardiology (JACC)

Study demonstrates promising new capabilities for MyoVista® ECG device in detecting Abnormal Cardiac Function SOUTHLAKE, Texas, April 10, 2018 - (BioPortfolio) HeartSciences, a medical device company leading innovation in electrocardiography through the application of continuous wavelet transform (CWT) signal processing and artificial intelligence announced today the results of a c...

Wednesday 28th March 2018

An effective model to study nanoparticle toxicity using stem cells

Nanomaterials in the form of engineered nanoparticles have been used in many daily consumer products including medical devices and diagnostics, anti-bacterial, food preservatives and packaging, household consumables. These particles are very small in size (<100 nm) and can easily enter the cell by direct uptake or by phagocytosis. After a significant number of nanoparticles enter the cells, t...

Thursday 8th March 2018

HeartSciences Announces Poster Presentation at the 2018 American College of Cardiology Scientific Sessions

HeartSciences also participates in the ACC Future Hub at Booth#3517, Space FH7 SOUTHLAKE, Texas, March 8, 2018 --(BUSINESSWIRE)—HeartSciences, an innovative medical device company, announced today that an abstract describing the detection of cardiac mechanical relaxation abnormalities using a 12-lead resting ECG that incorporates wavelet signal processing has been selected for a poster p...

As global topical and transdermal business booms, MedPharm ramps up investment at Durham, NC site

World leading service provider invests in $0.75M cutting edge instrumentation to further automated testing and expands workforce. MedPharm, the world leader in formulation and development services for topical and transdermal products, has announced internal investment of $0.75M on cutting edge instrumentation for its US facilities based in Durham, North Carolina. The investment covers the lat...

Monday 26th February 2018

Mundipharma’s novel device, k-haler®, recognised for innovative packaging by iF DESIGN AWARDS

CAMBRIDGE, 26 February 2018 – iF DESIGN AWARDS, one of the most important design awards in the world, have named the Mundipharma International Limited, which is part of the Mundipharma network of independent associated companies, amongst their winners. The k-haler® device triumphed in the Packaging Design discipline of the Medicine / Pharmaceutics category and was recognised for its...

Tuesday 20th February 2018

Positive Phase I results from Kancera for first in class immunoregulating drug KAND567 targeting fraktalkine pathway

Kancera AB (publ) reports positive results from a Phase I study in healthy subjects with its lead immunoregulating drug candidate KAND567. KAND567 is an orally available small molecule that blocks CX3CR1, the Fractalkine receptor. Fractalkine is an immunomodulating factor, known as a chemokine, which transmits signals via the CX3CR1 receptor, thereby controlling the function of immune cells and ...

Quick Search


News Quicklinks